Showing results (21-30 of 190) with videos related to
Sort By:
Pageof 19
Drug, Healthcare and Patient Safety|July 15, 2014
New developments in the treatment of metastatic melanoma - role of dabrafenib-trametinib combination therapyJason J Luke, Patrick A OttClinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2025
And… We're Back: The Reemergence of CD137 in Cancer Immunotherapy via Antigen AnchoringMatthew K Nguyen, Jason J LukeClinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2023
CD4+ TIL to the Rescue of Anti-PD-1 Failure by Targeting MHC-IIAllison Betof Warner, Jason J LukeClinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2021
Ipilimumab Combination Dosing: Less is MoreMax Jameson-Lee, Jason J LukeClinics in Dermatology|April 24, 2013
Chemotherapy in the management of advanced cutaneous malignant melanomaJason J Luke, Gary K SchwartzAmerican Journal of Clinical Dermatology|February 27, 2024
Rapidly Evolving Pre- and Post-surgical Systemic Treatment of MelanomaRyan C Augustin, Jason J LukeNEJM Evidence|February 6, 2024
Progression/Recurrence-Free Survival 2 in Adjuvant MelanomaRyan C Augustin, Jason J LukeCurrent Oncology Reports|August 3, 2021
Next-Generation Immunotherapy Approaches in MelanomaTyler Buchanan, Afsaneh Amouzegar, Jason J LukeGenome Medicine|October 27, 2020
Molecular correlates and therapeutic targets in T cell-inflamed versus non-T cell-inflamed tumors across cancer typesRiyue Bao, Daniel Stapor, Jason J LukeOncotargets and Therapy|October 29, 2020
Toll-Like Receptor 9 Agonists in CancerLilit Karapetyan, Jason J Luke, Diwakar DavarPageof 19